Combinatorial biosynthesis of reduced polyketides. Weissman, K. J. & Leadlay, P. F. Nature Reviews Microbiology, 3(12):925--936, December, 2005.
Combinatorial biosynthesis of reduced polyketides [link]Paper  doi  abstract   bibtex   
The bacterial multienzyme polyketide synthases (PKSs) produce a diverse array of products that have been developed into medicines, including antibiotics and anticancer agents. The modular genetic architecture of these PKSs suggests that it might be possible to engineer the enzymes to produce novel drug candidates, a strategy known as 'combinatorial biosynthesis'. So far, directed engineering of modular PKSs has resulted in the production of more than 200 new polyketides, but key challenges remain before the potential of combinatorial biosynthesis can be fully realized.
@article{weissman_combinatorial_2005,
	title = {Combinatorial biosynthesis of reduced polyketides},
	volume = {3},
	copyright = {© 2005 Nature Publishing Group},
	issn = {1740-1526},
	url = {http://www.nature.com/nrmicro/journal/v3/n12/full/nrmicro1287.html},
	doi = {10.1038/nrmicro1287},
	abstract = {The bacterial multienzyme polyketide synthases (PKSs) produce a diverse array of products that have been developed into medicines, including antibiotics and anticancer agents. The modular genetic architecture of these PKSs suggests that it might be possible to engineer the enzymes to produce novel drug candidates, a strategy known as 'combinatorial biosynthesis'. So far, directed engineering of modular PKSs has resulted in the production of more than 200 new polyketides, but key challenges remain before the potential of combinatorial biosynthesis can be fully realized.},
	language = {en},
	number = {12},
	urldate = {2016-08-11TZ},
	journal = {Nature Reviews Microbiology},
	author = {Weissman, Kira J. and Leadlay, Peter F.},
	month = dec,
	year = {2005},
	pages = {925--936}
}

Downloads: 0